Exhaustive analysis needed before notifying more medical devices: MtaI Medical devices are different from drugs, therefore cannot be treated as drugs in long run
AIMED Welcomes DTAB’s Move of Considering to Regulate all Medical Devices The Association, however, raises concern that many key strategic aspects of the roadmap discussed with the Indian Medical Devices…
Indian stent makers: No more on the fringes of business In India's price sensitive market, domestic stent manufacturers have fared well and are now capturing global markets By Raelene…
Devices as drugs: The debate continues The Centre’s notification on medical devices to be treated as drugs has created a difference of opinion with experts questioning…
J&J to pay Rs 74.5 lakh to first patient with faulty hip implant: CDSCO This is the first case where M/s Johnson & Johnson has been directed to pay compensation for its faulty ASR hip implant
Regulating medical devices The process of listening to each stakeholder and finding a balance could take months and even years